Blog

Lucia Masarova: Let’s tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Photo of Lucia Masarova taken from LinkedIn

Nov 22, 2023, 02:47

Lucia Masarova: Let’s tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared a post by Simrit Parmar, Assistant Professor of Stem Cell Transplant and Cellular Therapy at MD Anderson Cancer Centre on LinkedIn:

“Exciting, innovative, promising! Let’s tackle the inflammation in myelofibrosis! The era of combinational therapies is here.”

Quoting Simrit Parmar’s post:

“CXCR4 enriched T-Regulatory Cells Preferentially Home to Bone Marrow and Decrease Inflammation
oral presentation by Meixian Huang at 65th Annual American Society of Hematology meeting on Saturday, December 9, 2023 at 4:30 PM.”

For details click here.
Source: Lucia Masarova/LinkedIn and Simrit Parmar/LinkedIn

American Society of Hematology cancer Cellular Therapy CXCR4 Leukemia Lucia Masarova MD Anderson Cancer Center Meixian Huang myelofibrosis OncoDaily Oncology Simrit Parmar Stem Cell Transplant

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Special Coverage